Bellevue Life Sciences SPAC issues $800K convertible promissory note to Duksung Co., Ltd.

OSR Holdings, Inc.

Principal $800K, 5% simple interest; 7% if prepaid after March 31, 2025.
Automatically converts into common stock at $8.10/share upon Qualified PIPE closing (min $1.5M).
Qualified PIPE must occur before or simultaneously with business combination with OSR Holdings.
Maturity October 15, 2025; no prepayment before March 31, 2025 unless PIPE fails.
Note includes trust account waiver and escrow of 400K shares by BCM Europe AG.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.